Impact of Anamorelin with unresectable pancreatic, gastric and colorectal cancer patients for a quality of life, skeletal muscle index and malnutrition
Latest Information Update: 05 Oct 2022
At a glance
- Drugs Anamorelin (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- 30 Sep 2022 Planned End Date changed from 31 Jul 2023 to 30 Mar 2024.
- 30 Sep 2022 Status changed from suspended to recruiting.
- 02 Aug 2022 Status changed from recruiting to suspended.